Form 8-K - Current report:
SEC Accession No. 0001640334-18-000161
Filing Date
2018-01-22
Accepted
2018-01-22 16:34:08
Documents
5
Period of Report
2018-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nemus_8k.htm 8-K 22627
2 FORM OF RESTRICTED STOCK AGREEMENT nemus_ex42.htm EX-4.2 47195
3 SECURITIES PURCHASE AGREEMENT nemus_ex101.htm EX-10.1 337995
4 PRESS RELEASE nemus_ex991.htm EX-99.1 10485
5 nemus_ex6img1.jpg GRAPHIC 7582
  Complete submission text file 0001640334-18-000161.txt   430508
Mailing Address 600 ANTON BLVD, SUITE 1100 COSTA MESA CA 92626
Business Address 600 ANTON BLVD, SUITE 1100 COSTA MESA CA 92626 (949) 396-0330
Nemus Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55136 | Film No.: 18540182
SIC: 2834 Pharmaceutical Preparations